4//SEC Filing
Ren Ken Keyong 4
Accession 0001144204-18-063348
CIK 0000895051other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 1:23 PM ET
Size
5.6 KB
Accession
0001144204-18-063348
Insider Transaction Report
Form 4
Ren Ken Keyong
Chief Executive Officer
Transactions
- Award
Stock Options (Right to Buy)
2018-12-03+720,000→ 720,000 totalExercise: $0.99From: 2018-12-03Exp: 2027-08-14→ Common Stock (720,000 underlying)
Footnotes (1)
- [F1]On August 14, 2017, the reporting person was granted an option to purchase 720,000 shares of common stock that vest upon achievement of certain performance based conditions. The performance based condition was satisfied on December 3, 2018, resulting in vesting of the option.
Documents
Issuer
CASI Pharmaceuticals, Inc.
CIK 0000895051
Entity typeother
Related Parties
1- filerCIK 0001545181
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 1:23 PM ET
- Size
- 5.6 KB